“…Schematic representation of the molecules involved in the Wnt/β-catenin signaling in the inactive (left) and active (right) state: molecules, whose expression may be affected by genetic and epigenetic modifications in PCas, are indicated. The Wnt/β-catenin deregulation has been suggested as a “hub” of parathyroid tumorigenesis [37]. DKK1, Dickkopf 1; DVL, disheveled segment polarity protein; SFRP, secreted frizzled related protein; CKI, cyclin-dependent kinase inhibitor; GSK3, glycogen synthase kinase 3 β; TCF/LEF1, transcription factor 7/lymphoid enhancer binding factor 1; HIC1, hypermethylated in cancer 1; WT1, Wilms tumor 1; RASSF1A, Ras-association domain family 1; LRP-5, low density lipoprotein (LDL) receptor related protein 5; LRP-6, low density lipoprotein (LDL) receptor related protein 6; CDC73, cell division cycle 73; APC, WNT signaling pathway regulator; WNT, wingless-type ; ub, ubiquitination; ⊥, inhibitory effect.…”